IMI White Papers & Clinical Summaries

Research papers & clinical summaries

Starting with a World Health Organization (WHO) global scientific meeting on myopia at BHVI, Sydney in 2015,  the International Myopia Institute was then formed to continue the efforts of the meeting and address the challenges of myopia and high myopia.

Full IMI White Papers and translated IMI Clinical Summaries are available below.

IMI White Paper Taskforce Interviews

Access interviews with IMI White Paper taskforce chairs, providing a quick snapshot of key evidence available from our growing body IMI White Papers since 2019.

series one

Editorial: Myopia – A 21st Century Public Health Issue

IMI Myopia Control Reports Overview and Introduction

IMI Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies

IMI Report on Experimental Models of Emmetropization and Myopia

IMI Myopia Genetics Report

IMI Interventions for Controlling Myopia Onset and Progression Report

IMI Clinical myopia control trials and instrumentation report

IMI Industry guidelines and ethical considerations for myopia control

IMI Clinical Management Myopia Guidelines Report

Update and guidance on management of myopia

series two

IMI 2021 Reports and Digest – Reflection on the Implications for Clinical Practice

IMI Impact of Myopia

IMI Risk Factors for Myopia

IMI Accommodation and Binocular Vision in Myopia Development and Progression

IMI Pathologic Myopia

IMI Prevention of Myopia and its Progression

IMI 2021 Yearly Digest

series three

IMI 2023 White Papers Introduction

IMI Onset and Progression of Myopia in Young Adults

IMI Management and Investigation of High Myopia in Infants and Young Children

IMI – The Dynamic Choroid: New Insights, Challenges, and Potential Significance for Human Myopia

IMI Non-Pathological Human Ocular Tissue Changes with Axial Myopia

IMI Global trends in myopia management attitudes and strategies in clinical practice – 2022 Update

IMI 2023 Digest

Translation and Support

We would like to acknowledge the translators and support staff who have helped to further disseminate the IMI White Paper findings around the world in the following languages.

Nicole Xiao Liu MOptom, PhD Candidate
BHVI Sydney

Gabi Steenbekkers BOptom
Myopia Management Specialist at Procornea Nederland/ CooperVision Specialty Eyecare Division

IMI Series One
Translator: Professor Arnaud Sauer PhD, MD, FEBO
Senior Registrar, Department of Ophthalmology, Strasbourg University Hospital, France Professor of Ophthalmology, School of Medicine, Strasbourg University, France Head of the Grand Est Orthoptics’ School, Strasbourg University France
Reviewer: Dr Ornella Koumbo OD, PhD
BHVI Sydney

IMI Series Two
Translator: Mhamed Ouzzani MSc, PhD Candidate
Optometrist, Université de Montréal, Canada and Université Oran 1, Algeria
Reviewer: Professor Arnaud Sauer PhD, MD

Peter Wagner BOptom
BHVI Sydney

Dr Sotiris Plainis PhD, MSc, FBCLA
Research Fellow, Institute of Vision and Optics, Honourary Lecturer, University of Manchester (School of Life Sciences), Research Fellow, Aston University, England
Dr Eleni Poulere OD, MSc
Scientific Assistant, contact-lenses.gr, Heraklion, Greece

Oded Zvibach BOptom Optometrist, Professional Services Manager and Training, Crystal Optic Industries, Israel

IMI Series One
Translator: Maria Giulia Muzzi DipOptom, FAAO
Occhio x Occhio, Ferrara, Italy
Reviewer: Giancarlo Montani DipOptom, FBCLA
Corso di Ottica e Optometria, Dipartimento di Matematica e Fisica “Ennio De Giorgi”, Università del Salento, Lecce, Italy

IMI Series Two
Translator: Maria Giulia Muzzi DipOptom, FAAO
Occhio x Occhio, Ferrara, Italy
Reviewer: Dr. Fabrizio Zeri PhD
Dipartimento di Scienze dei Materiali, Università di Milano-Bicocca, Milano, Italy

IMI Series Three
Translator: Giancarlo Montani D.Optom  FBCLA, FAAO
Corso di Ottica e Optometria, Dipartimento di Matematica e Fisica “Ennio De Giorgi”, Università del Salento, Lecce, Italy

吉岡奈由太 Dr Nayuta Yoshioka BOptom, FAAO
PhD Lecturer, School of Optometry and Vision Science, University of New South Wales, Sydney

Dr Safal Khanal OD PhD, SOVS
University of Auckland, New Zealand

IMI Series One
Professor Edson Santos-Neto MD, PhD
Hospital das Clinicas, Faculty of Medicine of the University of São Paulo, Brazil

IMI Series Two
Professor Edson Santos-Neto 
MD, PhD
Hospital das Clinicas, Faculty of Medicine of the University of São Paulo, Brazil
Dr Patricia Ioschpe Gus MD, PhD
Ophthalmologist, Hospital de Clínicas de Porto Alegre, Brazil

IMI Series Three
Dr José Manuel González-Méijome PhD, FAAO, FBCLA
Professor, Universidade do Minho

IMI Series One
Translator: Professor Alexander Myagkov and team
Director of the Russian Academy of Medical Optics and Optometry, C уважением, Мягков Александр Владимирович, профессор, д.м.н. директор НОЧУ ДПО “Академия медицинской оптики и оптометрии
Translator: Professor Irina Smirnova Yuryevna MD, PhD
Director of the Siberian Paediatric Ophthalmological Society, С уважением, СЦПЛБ “Глазка” директор центра врач-офтальмолог к.м.н. Смирнова Ирина Юрьевна
Reviewer: Olga Prenat
VP Global Education and Professional Relations, Essilor International

IMI Series Two
Translator: Professor Irina Smirnova Yuryevna MD, PhD
Director of the Siberian Paediatric Ophthalmological Society, С уважением, СЦПЛБ “Глазка” директор центра врач-офтальмолог к.м.н. Смирнова Ирина Юрьевна
Reviewer: Dr Denis Plotnikov MD, PhD
Genetic Epidemiology Lab, Kazan State Medical University, Russia

Dr Luisa Casas Luque OD, PhD
BHVI Sydney

Dr Antonio Abengózar-Vela PhD, OD
Centro Óptico COAV, Castellón de la Plana, Spain

Dr Ariolfo Vazquez OD, FIACLE, FSLS
Ophthalmologist, Oftalmolaser Clinic, Cuenca-Ecuador

Dr. Jacinto Santodomingo-Rubido OD, MSc, PhD
Clinical Affairs Manager & Senior Research Scientist, Menicon Co.

Edgar Davilia-Garcia OD, FIACLE, FSLS, NCLE-AC                        Optometrist-Consultant, Bausch + Lomb

Translator: Dr Lovisa Fagerlund, Optometrist, MSc, FBCLA
Reviewer: Dr Karim Makdoumi, Ophthalmologist, MD, PhD

Professor Uğur Emrah Altıparmak MD, FICO
Professor of Ophthalmology, Acıbadem Ankara Hospital, Eye Clinic, Turkey

IMI Series One
Dr Minh Anh Tran OD
Optometry Department, Hanoi Medical University, Vietnam 

Undergraduate students:

  • Anh Quyen Bui
  • Quang Vu Duong
  • Thu Huong Ha
  • Trang Tran
  • Nhat Hoang Nguyen
  • Thuy Nguyen
  • Thu Pham
  • Thanh Nam Tong

IMI Series Two
Dr Minh Anh Tran OD
Optometry Department, Hanoi Medical University, Vietnam 

Undergraduate students:

  • Nguyen Thi Thuy Phuong
  • Pham Van Anh
  • Nguyen Hai Yen
  • Pham Thi Dung
  • Nguyen Nhat Hoang

IMI Series Three
Dr Huy Tran Dinh Minh MD. MSc.

Dr Pietro M. Kheir MD
Oncology Scientific Value Enabler (Medical Manager/ Medical Advisor) – Levant

The publication costs of the International Myopia Institute reports were supported by donations from the Brien Holden Vision Institute, Carl Zeiss Vision, CooperVision, Essilor, Alcon, and Vision Impact Institute.

Disclosure: S. Resnikoff, Brien Holden Vision Institute (C); J.B. Jonas,P;D. Friedman, None; M. He, None; M. Jong, None; J.J.Nichols, None; K. Ohno-Matsui, Novartis (F), Bayer (F), Santen (F), Senju (F); E.L. Smith III, Brien Holden Vision Institute (F), Tree House Eyes (C), SightGlass Vision (C), P; C.F. Wildsoet,P; H.R. Taylor, None; J.S. Wolffsohn, Alcon (F), Allergan (F), Aston EyeTech (F), Bausch & Lomb (F), BetterVision Ltd (F), Cooper-Vision (F, C), Eaglet Eye (F), European Union (F), Eyebag (F), EMPharma (F), EyeDocs (F), Gelflex (F), Innovate UK (F), Johnson & Johnson Vision Care (F, C, R), Lenstec (F), Medmont (F), Rayner (F), Tearlab (F), Th´ea (F), Optimec (F), Visioncare Research (F, C), Aston EyeTech (I), Atiya Vision (C), British Contact LensAssociation (C), University of Houston (C), Shire (C), Santen (C, R), RB (C), Santen (R), P; T.Y. Wong, Allergan (C), Bayer (C), Genentech (C), Novartis (C), Roche (C)

No citation data has been entered for this IMI Whitepaper